Last reviewed · How we verify

NCT05000333

Consequences of Covid-19 on the Psychological and Physical Health of the Nursing Staff and on Their Professional Activity.

Completed Last updated 18 August 2022
What this trial tests

trial testing Self-questionnaire in Work-related Illness in 50 participants. Completed in 28 April 2022.

Timeline
3 September 2021
Primary endpoint
15 March 2022
28 April 2022

Quick facts

Lead sponsorCentre Hospitalier Intercommunal Creteil
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date3 September 2021
Primary completion15 March 2022
Estimated completion28 April 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Intercommunal Creteil

Who can join

18 and older, any sex, with Work-related Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this research is to identify the consequences of the Covid-19 on the physical and psychological health of the nursing staff of the Intercommunal Hospital of Villeneuve-Saint-Georges and on their professional activity thanks to a self-questionnaire. This anonymous self-questionnaire is intended for all the CHIV care workers who were infected by the coronavirus during the first wave and identified by the occupational health service.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Self-questionnaire

Trials testing the same drug.

Other recruiting trials for Work-related Illness

Currently open trials in the same condition.

Other Centre Hospitalier Intercommunal Creteil trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05000333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing